Pantoprazole 20mg and 40mg tablets: Actavis launched generic version after key patent expiry in Germany, Ireland, Netherlands

Actavis launched Pantoprazole tablets in Germany, Ireland, and the Netherlands (as reported by Actavis Here) after the key patent EP166287 expired on 6 May (SPC expiry). This is Actavis Group’s first own brand launch of this molecule.
In Germany and the Netherlands, the product was also launched by Actavis’ third party sales division’s (Medis’) customers at the same time. Earlier this year, Medis’ customers launched the product in Hungary and Poland.IMS Health reported EU Brand sales of EUR1.1 bln in 2008.